Zobrazeno 1 - 10
of 272
pro vyhledávání: '"S. K. Zyryanov"'
Autor:
S. K. Zyryanov, I. N. Dyakov
Publikováno v:
Фармакоэкономика, Vol 17, Iss 2, Pp 129-136 (2024)
Objective: to conduct a clinical and economic study of acalabrutinib for the treatment of adult patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy in the Russian Federation.Material and
Externí odkaz:
https://doaj.org/article/338b38071e0947d4a72c818883742e92
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 0, Pp 88-90 (2024)
The article provides an analysis of modern methods of treatment of secondary progressive multiple sclerosis (SPMS). The only drug that has proven its effectiveness in all types of SPMS (with exacerbations and without exacerbations) is siponimod. Clin
Externí odkaz:
https://doaj.org/article/801c56066d954331893c62e836625fab
Autor:
O. I. Butranova, S. K. Zyryanov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 12, Iss 1, Pp 74-88 (2024)
The aim of the study was to analyze the literature sources for pharmacodynamic and pharmacokinetic features of gabapentin, providing its use in patients with neuropathic pain, as well as a comparative evaluation of its efficacy and safety when used i
Externí odkaz:
https://doaj.org/article/3c7977a478c84ac7a615c104efc5ab6f
Autor:
O. I. Butranova, S. K. Zyryanov
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 2, Pp 87-94 (2024)
Chronic musculoskeletal pain (CMSP) is one of the most common pathological conditions that limits patients' physical activity and reduces their quality of life. The analgesic and anti-inflammatory effects of non-steroidal anti-inflammatory drugs (NSA
Externí odkaz:
https://doaj.org/article/d4a36b2e671e471ebe3db4611038ed6a
Autor:
O. M. Drapkina, S. K. Zyryanov, R. N. Shepel, D. O. Orlov, E. A. Rogozhkina, P. V. Egorov, I. S. Yavelov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 5 (2024)
Many patients and some doctors associate the worsening of cardiovascular diseases with meteoropathy (changes in atmospheric pressure and air temperature). Opinion about lack of weather influence on the increase in overall morbidity and the lack of re
Externí odkaz:
https://doaj.org/article/044973b53ac64b0cb6f0e980f9139fa6
Autor:
S. K. Zyryanov, K. V. Orlova
Publikováno v:
Фармакоэкономика, Vol 16, Iss 4, Pp 550-569 (2024)
Objective: evaluation of the comparative pharmacoeconomic effectiveness of treatment sequences with prolgolimab as the first line and combination therapy with BRAF/MEK inhibitors as the second line versus a regimen with BRAF/MEK inhibitors as the fir
Externí odkaz:
https://doaj.org/article/a12c56f153ad4f14a5d4c141ed32857e
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 86-95 (2024)
Relevance. Monitoring of antibiotic resistance and the frequency of isolation of microorganisms at the regional level in each medical organization is of paramount importance for the implementation of epidemiological safety. Objective. To identify the
Externí odkaz:
https://doaj.org/article/65d58ec6947c43ceb94b84a2511d1ab7
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 4-14 (2024)
Introduction. Nosocomial infections are a common complication in patients treated in the intensive care unit (ICU). Microorganisms with multidrug resistance are one of the significant risk factors for death in this category of patients. Aim. To study
Externí odkaz:
https://doaj.org/article/dcd875fd108247fd8dea17769877523f
Autor:
S. K. Zyryanov, I. N. Dyakov
Publikováno v:
Фармакоэкономика, Vol 16, Iss 3, Pp 422-430 (2023)
Objective: to evaluate the pharmacoeconomic efficiency of atezolizumab (inhibitor of programmed death ligand 1 (PD-L1)) in comparison with other checkpoint inhibitors (inhibitors of programmed cell death protein 1 (PD-1)) in patients with advanced no
Externí odkaz:
https://doaj.org/article/5656c1d6fa50463293e6ecaf843b805f
Autor:
O. I. Butranova, S. K. Zyryanov
Publikováno v:
Oftalʹmologiâ, Vol 20, Iss 3, Pp 390-397 (2023)
Dosage forms for topical ocular administration are the basis of patient management in ophthalmology. The eye is a structure evolutionarily protected from the effects of xenobiotics by a number of physiological and anatomical barriers. The development
Externí odkaz:
https://doaj.org/article/f17a589d27f34329b2019d979c80083d